http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-112017000908-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a82962e22b6ae66d43ee1e8c950d93db
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-65616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C309-05
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6561
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
filingDate 2015-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_726799964460dcfff7ce29bfefa45edf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2cece21250c3aa551fda656a5e8e6ffe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_33f9f0585eb9f605e75b6155876c3c57
publicationDate 2022-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-112017000908-B1
titleOfInvention TENOFOVIR DISOPROXIL EDISYLATE SALT, CRYSTALLINE FORM, PHARMACEUTICAL COMPOSITION COMPRISING SUCH SALT, AS WELL AS A METHOD FOR PREPARING IT
abstract It is a new salt of tenofovir disoproxil edisylate that has the structure of chemical formula 1.
priorityDate 2014-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5481350
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550067
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419561672
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8032

Total number of triples: 26.